Cargando…
Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines
The use of nanoparticles encapsulating messenger RNA (mRNA) as a vaccine has recently attracted much attention because of encouraging results achieved in many nonviral genetic antitumor vaccination studies. Notably, in all of these studies, mRNA nanoparticles are passively targeted to dendritic cell...
Autor principal: | Phua, Kyle K. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706915/ https://www.ncbi.nlm.nih.gov/pubmed/26819957 http://dx.doi.org/10.1155/2015/680620 |
Ejemplares similares
-
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
por: Phua, Kyle K. L., et al.
Publicado: (2014) -
Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022) -
Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNA
por: Yeom, Ji-Hyun, et al.
Publicado: (2013) -
mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023) -
Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021)